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INTRODUCTION 
 
Nearly 60 years ago, in 1950 the Nobel Prize was awarded to three American 
researchers (P. S. Hench, E. C. Kendall, and T. Reichstein) for their discoveries relating to the 
hormones of the adrenal cortex, their structure and biological effects. Thence steroids have 
been basal monitoring and therapeutical requirements in the medical routine. 
Several experimental and clinical data show that physiological and pathological changes 
in steroid metabolism play an important role in the development of some diseases. The 
qualitative and quantitative determination of steroid hormones is important in medical 
diagnostics as well as in the investigation into the pathophysiology of various diseases, and 
can also help therapy.   
Among the various methods that may be applied to measure steroid hormones and their 
metabolites, the use of chromatographic methods and immunoessays are the most widespread 
currently. Individual steroid measurements (generally immunoessays) from serum, plasma, 
saliva and urine can be performed rapidly and easily and can mainly be automatized. Their 
disadvantage is that they provide information about the steroids present in the circulation only 
at the moment of sampling, so they do not inform us about the circadian rhythm of the 
hormonal secretion.  
The method known as urinary steroid profile is a multicomponent analysis, measuring 
several steroid groups simultaneously. The results of urinary measurements provide 
information relating to steroid metabolism in the glands and the periphery as well. By 
eliminating the daily fluctuations that are characteristic for certain steroids, measurements 
from urine collected during a period of 24 hours provide an overall picture concerning one-
day steroid metabolism, the metabolic pathways of steroids and also the functioning of the 
enzymes taking part in the synthesis. The other advantage is that the procedure is non-
invasive, and it is important in the case of examination of stress-related diseases.  
The urinary steroid profiling has outstanding importance in the differential diagnostics 
and research of several endocrine diseases. In Hungary, with medical diagnostic aims, urinary 
steroid profile tests are allowed to be performed only at the Institute of Bioanalysis, Faculty of 
Medicine, University of Pécs, being a member of an international organization that 
coordinates laboratories using this same method. 
We have examined urinary steroid profiles in some endocrine and psychiatric diseases 
with a complex endocrine background connected to the modification of steroid metabolism.  
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AIMS OF STUDY 
 
These days eating disorders and infertility problems are very common. Several risk 
factors have been identified in their development; however, their pathophysiology has not 
been completely cleared and can be associated with modified steroid metabolism. We wanted 
to study whether a specific urinary steroid profile of these diseases existed or whether the 
detected changes could be interpreted in the framework of diagnostics and therapy. 
 
1. Our goal was to recognise the changes of steroid metabolism in women with eating 
disorders. 
 
2. We wanted to investigate the urinary steroid profile of patients with poor and 
normal response to controlled ovarian stimulation. 
 
3. We aimed to recognize the changes of steroid metabolism prior to oocyte pick-up 
and three weeks after embryo transfer of women who underwent controlled 
ovarian stimulation. 
 
4. Our aim was to investigate the urinary steroid metabolite profiles for patients who 
failed to achieve pregnancy and for patients with ongoing pregnancy after in vitro 
fertilization  
 
5. We intended to compare the urinary steroid metabolite levels of women at the day 
of oocyte pickup with treated endometriosis and control women.  
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MATERIALS AND METHODS 
 
1. SUBJECTS 
 
24-hour collection of urine samples was applied. Patients from the clinics of the Faculty of 
Medicine, University of Pécs were chosen, with the help of clinicians according to severe 
criteria. 
The patients had not received medication influencing steroid metabolism, had not had 
endocrine or other serious diseases before the collection of urine samples, collected the urine 
samples precisely and agreed to take part in the research.  
The controls were age-matched healthy women from the Department of Obstetrics and 
Gynecology and from the Institute of Bioanalysis of the Faculty of Medicine, University of 
Pécs. 
 
2. DETERMINATION OF STEROID-PROFILE 
 
Before the gas chromatographic analysis we performed sample preparation consisting of 
the following steps: extraction of steroids from urine, releasing of metabolites secreted as 
conjugates by enzymatic hydrolysis, derivatisation of the polar groups (hydroxyl and keto 
groups) influencing heat degradation and volatility. We removed the silylating reagent excess 
by column chromatography. 
The steroid derivates were separated by gas chromatography. The separations were carried 
out in a capillary column with non-polar stationary phase. A mass spectrometer was used as 
detector. The quantitation of the metabolites was carried out in the selected ion monitoring 
mode. The Target Ion was used for the quantitative analysis of the steroid metabolites. The 
steroid identification in each sample was based on the ratio of Qualifier Ions to Target Ion and 
the difference between the retention times of each steroid. The quantification was obtained by 
relating the peak areas of the individual components to the area of the internal standard. 
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RESULTS AND DISCUSSION 
 
We studied the 24-hour urinary steroid metabolite profile of patients suffering from 
endocrine or neural pathographies affecting steroid metabolism. The 24-hour urinary steroid 
volumes measured in patient samples were compared to those of healthy control subjects of 
similar ages by way of statistical tests in compliance with the distribution of samples. 
 
1. Neuroendocrine studies have engaged in changes of cortisol (F) metabolism in eating 
disorders. It is known that high cortisol excretion is accompanied with eating disorders, but 
normal plasma level has been reported, too. The high cortisol level can be the effect of the 
hyperactivity of hypothalamic-pituitary-adrenal (HPA) axis. We could not detect significant 
differences in the urinary cortisol level and in the sum of cortisol metabolites in patients. 
However, in five patients the mean values of the total cortisol metabolites were very high, 
supporting others’ findings and pointing out the important role of cortisol and its metabolites 
in eating disorders. Further investigations are required to clarify the reason of the different 
results. 
The increased level of the stress marker allo-tetrahydrocorticosterone (aTHB) in the urine 
of young women with eating disorders shows the stress involvement in these diseases, which 
may derive from their continuous dissatisfaction with their body shape.  
An increasing interest in the role of dehydroepiandrosterone and dehydroepiandrosterone 
sulfate in different diseases is observable among researchers. Their effect has been studied in 
breast cancer, osteoporosis, depression etc. Our findings on the significantly changed urinary 
dehydroepiandrosterone level suggest the possibility of the therapeutical use of this 
component in human eating disorders. 
 
2. The success of in vitro fertilization and other assisted reproductive technologies is 
critically dependent on optimizing ovarian stimulation protocols that try to provide good 
quality oocytes and embryos. Poor responder patients characteristically have low oocyte yield, 
high cancellation rate, and few available embryos for transfer. The cause of poor ovarian 
response is not cleared yet. In some cases it correlates with advanced reproductive age (>40 
years). Other factors, such as advanced endometriosis, as well as previous ovarian surgery can 
lead to a poor ovarian response.  
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Certain studies notified altered ovarian steroidogenesis, as assessed by follicular steroid 
levels in women undergoing controlled ovarian hyperstimulation using Gonadotropin-
releasing hormone (GnRH) agonists. Likewise differences in the role of granulosa-luteal cells 
were found in patients undergoing IVF with GnRH agonists and antagonists. It was confirmed 
that the follicular level of estradiol was decreased in poor responders, and granulosa cells of 
poor responders produced significantly less progesterone than those of normoresponders. It is 
consistent with our results, but we found just one progesterone metabolite (5-PD) that was 
significantly decreased in poor responders. The urinary level of another progesterone 
metabolite (pregnanediol) was also lower, but not to a level of statistical significance. The rest 
of progesterone metabolites did not differ between poor responder and normoresponder 
groups. Furthermore we have shown decreased levels of urinary dehydroepiandrosterone 
(DHEA) in poor responders. In terms of the other androgen metabolites and all of the 
corticoids the two groups did not vary. The adrenal cortex is the site of massive formation of 
very weak androgenic steroids, DHEA and DHEA-sulphate, which are partially converted to 
more potent androstenedione and testosterone in the periphery. Our findings on the 
significantly decreased level of the DHEA point to the role of testosterone, androstenedione 
and DHEA in poor ovarian response. In addition some studies have shown decreased levels of 
follicular fluid testosterone in poor responders. Others have found that DHEA improved 
response to ovarian stimulation even after controlling for gonadotrophin dose.  
Based on the above results, we suppose that ovarian granulosa cell steroid production is 
adversely altered in poor responders.  
It is needful to point out that our study was executed in vivo, whereby we compared the 
actual urinary concentrations of steroid metabolites. We did not execute in vitro experiments 
to determine whether the groups differed in granulosa cell function following gonadotrophin 
stimulation.  
 
3. Successful embryo transfer 
The hormonal events surrounding implantation and early pregnancy are complex and still 
poorly understood. The concentrations of androsterone (An), etiocholanolone (Et), 
pregnanediol (PD), tetrahydro-11-dehydrocorticosterone (THA) and tetrahydro-corticosterone 
(THB) were significantly higher three weeks after embryo transfer compared to the values 
obtained before the oocyte retrieval in patients with a successful pregnancy. The An and Et 
are androgen metabolites, the PD is a progesterone derivative, THA and THB are 
corticosterones.  
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The increased levels of two androgens, androsterone and etiocholanolone, in patients with 
an ongoing IVF pregnancy may originate from the increased production by the ovaries or 
adrenal glands, from increased peripheral aromatase activity, or from decreased clearance 
from the body. The significantly increased androgen metabolite levels are very interesting 
findings. Previous studies have described that the elevation of the androgen concentration is 
one of the important factors that might cause miscarriage, which is contradictory with our 
results. Some studies have highlighted an association between high testosterone 
concentration, abnormal endometrial development and adverse pregnancy outcome.  
The increased level of pregnanediol is obviously connected to the progesterone production. 
The most likely reason for the stable high progesterone levels is that IVF induction methods 
result in multiple luteinized follicles. Some studies measured high concentrations of 
progesterone during the first trimester. Csapo et al. proved the importance of progesterone 
during the first weeks of pregnancy. They found that the removal of the corpus luteum prior to 
the seventh week of gestation led to pregnancy loss, but pregnancy could be maintained even 
after removal of the corpus luteum by external administration of progesterone. Progesterone 
also helps with uterine smooth muscle quiescence and local vasodilatation, by inducing nitric 
oxide synthesis in the decidua.  
The function of the hypothalamic-pituitary-adrenal axis is altered during pregnancy. The 
increased levels of tetrahydro-11-dehydrocorticosterone and tetrahydro-corticosterone point to 
the role of corticosterones in early pregnancy and fetal development. Previous studies have 
found that plasma corticosterone concentrations increased with the progress of the pregnancy. 
 
Unsuccessful embryo transfer 
In the group of patients who failed to achieve pregnancy, the concentrations of 
tetrahydrocortisone (THE), tetrahydrocortisol (THF), allo-tetrahydrocortisol (aTHF) and α-
cortolone (α-CL) were significantly higher three weeks after the embryo transfer compared to 
the values obtained prior to oocyte retrieval. THE and -CL are cortisone metabolites, THF 
and aTHF originate from cortisol. 
Cortisol may influence the production of luteal progesterone. Some studies have reported a 
negative association between cortisol and progesterone around the time of implantation. The 
discovery of corticotrophin-releasing factor receptors on the ovary is also consistent with the 
possible existence of a down-regulatory effect of stress on steroidogenesis. Other studies have 
shown that hormones of the hypothalamic-pituitary-adrenal axis are able to suppress gonadal 
function by inhibiting GnRH release.  
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4. The hormonal events in early pregnancy are very complex processes, and still poorly 
understood. We found that the concentrations of pregnanediol (PD) and pregnanetriol (PT) 
(progesterone metabolites) are significantly higher, and the concentration of tetrahydrocortisol 
(THF) (a cortisol metabolite) is significantly lower in pregnancy. 
The endocrine system and the immune system interact closely during the maintenance of 
the pregnancy. At the decidua, under the influence of sex steroids, there is a dramatic increase 
of a unique population of lymphocytes, the uterine natural killer (uNK) cells in early 
pregnancy. The role of these cells in human pregnancy is still not definitively established. 
However, they are believed to promote placental and trophoblast growth and provide 
immunomodulation at the maternal-fetal interface. Uterine natural killer cells are hormonally 
regulated by progesterone, estrogen and prolactin. 
In the pregnant group the lower level of THF (compared to the group failing to achieve 
pregnancy) is probably a maternal adaptation to the pregnancy. In the non-pregnant group the 
higher THF level suggests the chance of possible miscarriages. The increased cortisol level 
may decrease the production of progesterone around the time of implantation.  
Furthermore, immune challenges in mice appear to promote a shift in the Th1/Th2 
cytokine ratio, which has been associated with low progesterone levels and early spontaneous 
abortion. It was found in rabbit cell-culture studies that glucocorticoids can cause 
degeneration and premature aging of the trophoblast. 
5. We compared the urinary steroid metabolite levels at the day of oocyte pickup of 
women treated with endometriosis and control women. We did not find significant differences 
in the androgen, progesterone or corticoid metabolites.  
Studies have reported increased progesterone levels in the follicular fluid at the day of 
oocyte pick-up in patients who underwent controlled ovarian stimulation. In these patients 
there was a connection between the progesterone level and the severity of endometriosis, 
while the testosterone level in the follicular fluid was reciprocally proportional to the severity 
of the disease.  
Our results do not reflect this; further investigations are needed to clear the question. 
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CONCLUSIONS 
I studied the gas-chromatographical steroid-profile method that can determine urinary 
steroid metabolites. 
This method can be applied in endocrinology, gynecology, pediatrics, dermatology, 
neurology and medicine, since the profiles have important diagnostical values in adrenal and 
gonadal diseases having characteristic steroid profile.  
The investigated psychiatric and gynecological diseases, statuses have complex 
endocrine background, steroid hormones play multiple and half-known roles in their 
pathophysiology. We observed changes in the steroid profile in several cases in the examined 
diseases compared to the same age and same sex control or patient groups. 
 
 
Main results: 
 
1. Our results confirm the role of dehydroepiandrosterone in eating disorders, therefore 
we have raised the possibility of its therapeutical use. The increased level of the stress 
marker allo-tetrahydrocorticosterone refers to the involvement of stress in these 
diseases, but the relevance of hormone alteration to the pathophysiology of eating 
disorders remains to be elucidated.  
 
2. We pointed out that ovarian granulosa cell steroid production is adversely altered in 
poor responders, therefore significantly lower progesterone production can be 
observed. Our findings on the significantly decreased level of the 
dehydroepiandrosterone point to the role of testosterone, androstenedione and 
dehydroepiandrosterone in poor ovarian response. The decreased level of 
dehydroepiandrosterone in poor responders suggests the possibility of the 
therapeutical use of the component. 
  
10 
 
3. The increased level of pregnanediol in patients with ongoing pregnancy highlights the 
key role of the progesterone during the first trimester. We pointed out the importance 
of corticosterones in early pregnancy and embryonal development with the altered 
level of tetrahydro-11-dehydrocorticosterone and tetrahydro-corticosterone. The 
significantly increased androsterone and etiocholanolone levels seem to contradict the 
results of previous studies that described the elevation of the androgen concentration 
as one of the important factors that might cause miscarriage. Further researches are 
required to clarify this outcome. 
 
We confirmed the possible existence of a down-regulatory effect of stress on 
steroidogenesis, with the high cortisone and cortisol metabolite levels in patients who 
failed to achieve pregnancy. We found a negative association between cortisol and 
progesterone around the time of implantation, which can be important in maintaining 
pregnancy.  
 
We found that the concentrations of pregnanediol and pregnanetriol were significantly 
higher, and the concentration of tetrahydrocortisol was significantly lower in pregnant 
patients than in women who failed to achieve pregnancy. The study concludes that the 
production of pregnanediol, pregnanetriol and tetrahydrocortisol is altered in early 
pregnancy. In the pregnant group the lower level of tetrahydrocortisol is a maternal 
adaptation to the pregnancy.  
 
4. We did not find significant differences in the androgen, progesterone or corticoid 
metabolites between women with treated endometriosis and control women. Some 
previous studies observed higher levels of progesterone, other studies show lower 
levels of testosterone in the follicular fluid. Further investigations are needed to clear 
this question.  
 
 
Similar changes found in the level of certain metabolites are accompanied by various 
symptoms in different diseases. Therefore the urinary steroid metabolite determination is 
suitable for detecting the changes; however, to explain the exact role of different components 
further tissue-specific examinations are necessary. 
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